FOI release

FOI2021/00157: UK-CTAP

This request was refused in part, so we didn't provide some of the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2021/00157

Published 2 July 2021

Request

Request Received: 18 March 2021

On the Gov.UK website under, Guidance: making a proposal for COVID-19 therapeutics clinical trials (https://www.gov.uk/government/publications/covid-19-treatments-making-a-proposal-for-clinical-trials/guidance-making-a-proposal-for-covid-19-therapeutics-clinical-trials - it states that:

"The UK-CTAP will be supported by a UK Research and Innovation (UKRI) led secretariat. The membership of the group and the record of the meetings will be published and updated periodically to reflect any changes in the membership details and the drug prioritisation process.

The panel will take specialist advice from sub-panels with expertise in strategically important areas for the treatment of COVID-19. These areas will change as we learn more about disease mechanisms in COVID-19 and its complications, and we advance our knowledge of the most effective treatments."

Please can you provide:

i) Electronic copies of UK-CTAP meeting minutes and;

ii) an excel spreadsheet as of the present date of this email to provide the total number of therapeutic compound proposals that have been received (identified by the submitting organisation and the date submitted to the Therapeutics Taskforce) and in the order the proposals were received.

Please provide the type of therapeutic, the date of the UK-CTAP review and outcome of the review such as - take no further or propose to enter the RECOVERY+, REMAP-CAP, PRINCIPLE or AGILE.

Proposed Excel headings are: Date submission received, Submitting Organisation, Compound name/type (ie Monoconal/small molecule/), Date reviewed by UK -CTAP, Review outcome (Recommended/Not recommended), Recommended for RECOVERY+, REMAP-CAP, PRINCIPLE or AGILE)

Response

Response Sent: 30 April 2021

Full details of this response are provided in the attached documents.

Documents

• FOI2021-00157 Copy of FOI REDACTED LIST OF SUBMISSIONS.xlsx (29.7 KB)
• FOI2021-00157 Copy of Trial Recommendations.xlsx (17.3 KB)
• FOI_Response_Letter_FOI2021_00157_Redacted.pdf (295.1 KB)

This is UK Research and Innovation's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.